Fibroblastic and myofibroblastic tumors explained

Fibroblastic and myofibroblastic tumors
Field:	Pathology, Dermatology, General surgery, Oncology, Surgical oncology
Types:	Benign, locally invasive, rarely metastasizing, malignant

Fibroblastic and myofibroblastic tumors (FMTs) are tumors which develop from the mesenchymal stem cells which differentiate into fibroblasts (the most common cell type in connective tissue) and/or the myocytes/myoblasts that differentiate into muscle cells. FMTs are a heterogeneous group of soft tissue neoplasms (i.e. abnormal and excessive tissue growths). The World Health Organization (2020) defined tumors as being FMTs based on their morphology and, more importantly, newly discovered abnormalities in the expression levels of key gene products made by these tumors' neoplastic cells.^[1] Histopathologically, FMTs consist of neoplastic connective tissue cells which have differented into cells that have microscopic appearances resembling fibroblasts and/or myofibroblasts. The fibroblastic cells are characterized as spindle-shaped cells with inconspicuous nucleoli that express vimentin, an intracellular protein typically found in mesenchymal cells, and CD34, a cell surface membrane glycoprotein. Myofibroblastic cells are plumper with more abundant cytoplasm and more prominent nucleoli; they express smooth muscle marker proteins such as smooth muscle actins, desmin, and caldesmon.^[2] The World Health Organization further classified FMTs into four tumor forms based on their varying levels of aggressiveness: benign, intermediate (locally aggressive), intermediate (rarely metastasizing), and malignant.^[1]

Benign FMTs

• Nodular fasciitis^[3]
• Proliferative fasciitis and proliferative myositis, originally considered separate entities, are now considered to differ only in the tissues involved.^[4]
• Myositis ossificans and fibro-osseous pseudotumor of digits, previously considered separate but similar tumors, are reclassified as being virtually identical neoplastic bone-forming tumors.^[3]
• Ischaemic fasciitis, previously termed atypical decubital fibroplasia or decubital ischemic fasciitis, was thought to be a non-neoplastic lesion and to occur only in the deep subcutaneous tissue at pressure points or bone prominences but more recently has been found to be a benign neoplasm that can occur in a wider range of tissue sites.^{[5] [6]}
• Elastofibroma, also termed elastofibroma dorsi, were originally considered separate tumors with bone-forming capacity but are now considered as belonging to the same neoplastic spectrum ^[3]
• Fibrous hamartoma of infancy^[7]
• Fibromatosis colli, also termed sternomastoid tumor of infancy, sternocleidomastoid pseudotumors, and congenital torticollis^[8]
• Juvenile hyaline fibromatosis, also termed fibromatosis hyalinica multiplex juvenilis and the Murray–Puretic–Drescher syndrome, an autosomal recessive inherited genetic disease.^[9]
• Infantile digital fibromatosis, also termed inclusion body fibromatosis^[10] or Reye tumor^[11]
• Fibroma of tendon sheath^[12]
• Desmoplastic fibroblastoma, also termed collagenous fibroma.^[13]
• Mammary-type myofibroblastoma^[14]
• Myofibrobastoma, also termed myofibroblastoma of soft tissues, is a mammary-type myofibroblastoma that occurs in non-mammary tissues^[15] and may be as much as 10-fold more common than the mammary type.^[14]
• Calcifying aponeurotic fibroma, also termed aponeurotic fibroma^[16]
• EWSR1-SMAD3-positive fibroblastic tumor, also termed EWSR1-SMAD3-rearranged fibroblastic tumor, is classified as an emerging (i.e. recently characterized^[17]) entity by the World Health Organization, 2020.^[18] It is a benign, small tumor located in the skin of the distal areas of the legs and, less commonly, the arm; it has occurred mostly in females. EWSR1-SMAD3-positive fibroblastic tumor was named based on the finding that its tumor cells express a EWSR1-SMAD3 fusion gene. Since its initial description in 2018, a total of 15 cases have been reported as of 2021.^{[17] [19]}
• Angiomyofibroblastoma^[20]
• Cellular angiofibroma, an angiofibroma that is a benign, usually small, slow-growing tumor arising in the groin, scrotal or vulva regions.^[15]
• Angiofibroma of soft tissue, also termed angiofibroma NOS (NOS indicates Not Otherwise Specified), an angiofibroma that develops in the extremities, particularly around or in the large joints.^[21]
• Nuchal fibroma^[22]
• Superficial acral fibromyxoma, also termed acral fibromyxoma.^[15]
• Gardner fibroma, a benign proliferation of thick, irregularly arranged collagen bundles with interspersed fibroblasts often association with the genetic disease of familial adenomatous polyposis^[23] and its variant, the Gardner's syndrome.^[24]

Intermediate (locally aggressive) FMTs

• Palmer/plantar-type fibromatosis, also known as plantar fibroma and Ledderhose disease.^[25]
• Desmoid-type fibromatosis, also termed desmoid tumor and aggressive fibromatosis^[26]
• Lipofibromatosis, a mixture of lipofibromatosis tumors with different gene abnormalities;^[27] these tumors differ from lipofibromatosis-like neural tumors which have not been classified as fibroblastic and myofibroblastic tumors.
• Giant cell fibroblastoma^[28]
• Dermatofibrosarcoma protuberans^[29]
• Fibrous hamartoma of infancy^[7]

Intermediate (rarely metastasizing) FMTs

• Dermatofibrosarcoma protuberans, fibrosarcomatous, also termed fibrosarcomatous dermatofibrosarcoma protuberans (or fibrosarcomatous DFSP), is a more aggressive tumor than dermatofibrosarcoma protuberans tumors).^[29]
• Solitary fibrous tumour, also fibrous termed tumor of the pleura.^[30]
• Inflammatory myofibroblastic tumour^[31]
• Low-grade myofibroblastic sarcoma^[32]
• Superficial CD34-positive fibroblastic tumour^[33]
• Myxoinflammatory fibroblastic sarcoma,^[34] also termed acral myxoinflammatory fibroblastic sarcoma because it was initially thought to be limited to acral (i.e. leg and arm) areas.^[35]
• Infantile fibrosarcoma, also termed congenital infantile fibrosarcoma and fibrosarcoma, infantile type.^[36]

Malignant FMTs

• Solitary fibrous tumor, malignant type, a malignant form of the solitary fibrous tumors^[37]
• Fibrosarcoma NOS, i.e. fibrosarcoma, not otherwise specified, or, alternatively, adult fibrosarcoma to distinguish it from rarely metastasizing infantile fibrosarcoma.^{[36] [38]}
• Myxofibrosarcoma, once classified as a histiocyte-derived histiocytoma now reclassified as a fibroblastic/myofibroblastic tumor.^[39]
• Low-grade fibromyxoid sarcoma^[32]
• Sclerosing epithelioid fibrosarcoma^{[36] [40]}

See also

Plexiform angiomyxoid myofibroblastic tumor

Notes and References

1. Sbaraglia M, Bellan E, Dei Tos AP . The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives . Pathologica . 113 . 2 . 70–84 . April 2021 . 33179614 . 8167394 . 10.32074/1591-951X-213 .
2. Slack JC, Bründler MA, Nohr E, McIntyre JB, Kurek KC . Molecular Alterations in Pediatric Fibroblastic/Myofibroblastic Tumors: An Appraisal of a Next Generation Sequencing Assay in a Retrospective Single Centre Study . Pediatric and Developmental Pathology . 24. 5. 405–421 . May 2021 . 33970051 . 10.1177/10935266211015558 . 234348021 .
3. Nakayama S, Nishio J, Aoki M, Koga K, Nabeshima K, Yamamoto T . Ubiquitin-specific Peptidase 6 (USP6)-associated Fibroblastic/Myofibroblastic Tumors: Evolving Concepts . Cancer Genomics & Proteomics . 18 . 2 . 93–101 . 2021 . 33608306 . 7943209 . 10.21873/cgp.20244 .
4. Makise N, Mori T, Motoi T, Shibahara J, Ushiku T, Yoshida A . Recurrent FOS rearrangement in proliferative fasciitis/proliferative myositis . Modern Pathology . 34 . 5 . 942–950 . May 2021 . 33318581 . 10.1038/s41379-020-00725-2 . 228627775 . free .
5. Kuyumcu G, Zhang Y, Ilaslan H . Case 272: Decubital Ischemic Fasciitis . Radiology . 293 . 3 . 721–724 . December 2019 . 31751192 . 10.1148/radiol.2019171255 . 208227281 .
6. Fukunaga M . Atypical decubital fibroplasia with unusual histology . APMIS . 109 . 9 . 631–5 . September 2001 . 11878717 . 10.1034/j.1600-0463.2001.d01-185.x . 29499215 .
7. Martos-Cabrera L, Sampedro-Ruiz R, Pérez-González YC, Mentzel T, Llamas-Velasco M . Fibrous Hamartoma of Infancy: A Series of 21 Cases and Review of the Literature . Actas Dermo-sifiliograficas . 112 . 6 . 520–527 . June 2021 . 34088477 . 10.1016/j.adengl.2021.03.010 . free .
8. Durnford L, Patel MS, Khamar R, Khurram R . Bilateral sternocleidomastoid pseudotumors-a case report and literature review . Radiology Case Reports . 16 . 4 . 964–967 . April 2021 . 33664922 . 7897923 . 10.1016/j.radcr.2021.02.001 .
9. Braizat O, Badran S, Hammouda A . Juvenile Hyaline Fibromatosis: Literature Review and a Case Treated With Surgical Excision and Corticosteroid . Cureus . 12 . 10 . e10823 . October 2020 . 33173631 . 7645300 . 10.7759/cureus.10823 . free .
10. Agnihotri MA, Sathe PA . Inclusion body fibromatosis - A report of four cases and review of literature . Journal of Postgraduate Medicine . 67 . 1 . 24–26 . 2021 . 33565473 . 8098864 . 10.4103/jpgm.JPGM_774_20 . free .
11. Adegoke OO, Ajao AE, Ano-Edward GH . Congenital infantile digital fibromatosis: a case report and review of the literature . African Health Sciences . 20 . 4 . 1865–1869 . December 2020 . 34394250 . 10.4314/ahs.v20i4.42 . 8351811 .
12. Pižem J, Matjašič A, Zupan A, Luzar B, Šekoranja D, Dimnik K . Fibroma of tendon sheath is defined by a USP6 gene fusion-morphologic and molecular reappraisal of the entity . Modern Pathology . 34. 10. 1876–1888. June 2021 . 34088995 . 10.1038/s41379-021-00836-4 . 235327044 . free .
13. Nakayama S, Nishio J, Aoki M, Nabeshima K, Yamamoto T . An Update on Clinicopathological, Imaging and Genetic Features of Desmoplastic Fibroblastoma (Collagenous Fibroma) . In Vivo (Athens, Greece) . 35 . 1 . 69–73 . 2021 . 33402451 . 7880796 . 10.21873/invivo.12233 . 0258-851X .
14. Howitt BE, Fletcher CD . Mammary-type Myofibroblastoma: Clinicopathologic Characterization in a Series of 143 Cases . The American Journal of Surgical Pathology . 40 . 3 . 361–7 . March 2016 . 26523539 . 10.1097/PAS.0000000000000540 . 45911598 .
15. Libbrecht S, Van Dorpe J, Creytens D . The Rapidly Expanding Group of RB1-Deleted Soft Tissue Tumors: An Updated Review . Diagnostics (Basel, Switzerland) . 11 . 3 . March 2021 . 430 . 33802620 . 8000249 . 10.3390/diagnostics11030430 . free .
16. John I, Fritchie KJ . What is new in pericytomatous, myoid, and myofibroblastic tumors? . Virchows Archiv . 476 . 1 . 57–64 . January 2020 . 31705190 . 10.1007/s00428-019-02700-y . 207941071 .
17. Foot O, Hallin M, Jones RL, Sumathi VP, Thway K . EWSR1-SMAD3-Positive Fibroblastic Tumor . International Journal of Surgical Pathology . 29 . 2 . 179–181 . April 2021 . 32615834 . 10.1177/1066896920938124 . 220326585 .
18. Dermawan JK, Ko JS, Billings SD . Update on Cutaneous Soft Tissue Tumors . Surgical Pathology Clinics . 14 . 2 . 195–207 . June 2021 . 34023100 . 10.1016/j.path.2021.03.002 . 235169042 .
19. Habeeb O, Korty KE, Azzato EM, Astbury C, Farkas DH, Ko JS, Billings SD . EWSR1-SMAD3 rearranged fibroblastic tumor: Case series and review . Journal of Cutaneous Pathology . 48 . 2 . 255–262 . February 2021 . 32901982 . 10.1111/cup.13870 . 221572166 .
20. Chapel DB, Cipriani NA, Bennett JA . Mesenchymal lesions of the vulva . Seminars in Diagnostic Pathology . 38 . 1 . 85–98 . January 2021 . 32958293 . 10.1053/j.semdp.2020.09.003 . 221842800 .
21. Purkait S, Mitra S, Adhya AK, Sethy M, Mishra TS . Cytology of angiofibroma of soft tissue of the inguinal region . Cytopathology . 33. 2. 276–280. July 2021 . 34273199 . 10.1111/cyt.13039 . 236034719 .
22. Kostakis ID, Feretis T, Damaskos C, Garmpis N, Liapis G, Pateras I, Garmpi A, Georgakopoulou VE, Antoniou EA . Nuchal-type Fibroma: Single-Center Experience and Systematic Literature Review . In Vivo (Athens, Greece) . 34 . 5 . 2217–2223 . 2020 . 32871744 . 7652458 . 10.21873/invivo.12032 .
23. Baranov E, Hornick JL . Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck . Head and Neck Pathology . 14 . 1 . 43–58 . March 2020 . 31950474 . 7021862 . 10.1007/s12105-019-01104-3 .
24. Coffin CM, Hornick JL, Zhou H, Fletcher CD . Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas . The American Journal of Surgical Pathology . 31 . 3 . 410–6 . March 2007 . 17325483 . 10.1097/01.pas.0000213348.65014.0a . 25831659 .
25. Stewart BD, Nascimento AF . Palmar and plantar fibromatosis: a review . Journal of Pathology and Translational Medicine . 55 . 4 . 265–270 . July 2021 . 34225446 . 10.4132/jptm.2021.06.14 . 8353138 .
26. Burney IA, Kakaria AK, Al-Jahdhami S . Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis . Sultan Qaboos University Medical Journal . 21 . 2 . e327–e328 . May 2021 . 34221486 . 8219336 . 10.18295/squmj.2021.21.02.027 .
27. Malik F, Santiago T, Newman S, McCarville B, Pappo AS, Clay MR . An addition to the evolving spectrum of lipofibromatosis and lipofibromatosis-like neural tumor: Molecular findings in an unusual phenotype aid in accurate classification . Pathology, Research and Practice . 216 . 6 . 152942 . June 2020 . 32299759 . 10.1016/j.prp.2020.152942 . 215803522 .
28. Web site: Giant cell fibroblastoma. .
29. Xiong JX, Cai T, Hu L, Chen XL, Huang K, Chen AJ, Wang P . Risk factors related to postoperative recurrence of dermatofibrosarcoma protuberans: A retrospective study and literature review . World Journal of Clinical Cases . 9 . 20 . 5442–5452 . July 2021 . 34307598 . 8281415 . 10.12998/wjcc.v9.i20.5442. 2307-8960 . free .
30. Zhang J, Liu J, Zhang Z, Tian B . Solitary Fibrous Tumors of the Chest: An Analysis of Fifty Patients . Frontiers in Oncology . 11 . 697156 . 2021 . 34277442 . 8280784 . 10.3389/fonc.2021.697156 . free .
31. Casanova M, Brennan B, Alaggio R, Kelsey A, Orbach D, van Noesel MM, Corradini N, Minard-Colin V, Zanetti I, Bisogno G, Gallego S, Merks JH, De Salvo GL, Ferrari A . Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG) . European Journal of Cancer . 127 . 123–129 . March 2020 . 32007712 . 10.1016/j.ejca.2019.12.021 . 211012731 .
32. Mohamed M, Fisher C, Thway K . Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features . Annals of Diagnostic Pathology . 28 . 60–67 . June 2017 . 28648941 . 10.1016/j.anndiagpath.2017.04.001 .
33. Lin TL, Yang CS, Juan CK, Weng YC, Chen YJ . Superficial CD34-Positive Fibroblastic Tumor: A Case Report and Review of the Literature . The American Journal of Dermatopathology . 42 . 1 . 68–71 . January 2020 . 30702454 . 10.1097/DAD.0000000000001355 . free .
34. Wangsiricharoen S, Ali SZ, Wakely PE . Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature . Journal of the American Society of Cytopathology . 10 . 3 . 310–320 . 2021 . 33431307 . 10.1016/j.jasc.2020.12.004 . 231585966 .
35. Tivoli YA, Thomas JA, Chen AF, Weiss ET . Acral myxoinflammatory fibroblastic sarcoma successfully treated using Mohs micrographic surgery . Dermatologic Surgery . 39 . 11 . 1709–11 . November 2013 . 24118192 . 10.1111/dsu.12308 . 39916092 .
36. Martínez-Trufero J, Cruz Jurado J, Gómez-Mateo MC, Bernabeu D, Floría LJ, Lavernia J, Sebio A, García Del Muro X, Álvarez R, Correa R, Hernández-León CN, Marquina G, Hindi N, Redondo A, Martínez V, Asencio JM, Mata C, Valverde Morales CM, Martin-Broto J . Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS - GROUP). Part I . Cancer Treatment Reviews . 99 . 102259 . July 2021 . 34311246 . 10.1016/j.ctrv.2021.102259 . 0305-7372 .
37. Martin-Broto J, Mondaza-Hernandez JL, Moura DS, Hindi N . A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons . Cancers . 13 . 12 . June 2021 . 2913 . 34200924 . 8230482 . 10.3390/cancers13122913 . free .
38. Hansen T, Katenkamp K, Brodhun M, Katenkamp D . Low-grade fibrosarcoma--report on 39 not otherwise specified cases and comparison with defined low-grade fibrosarcoma types . Histopathology . 49 . 2 . 152–60 . August 2006 . 16879392 . 10.1111/j.1365-2559.2006.02480.x . 39305599 .
39. Clarke LE . Fibrous and fibrohistiocytic neoplasms: an update . Dermatologic Clinics . 30 . 4 . 643–56, vi . October 2012 . 23021051 . 10.1016/j.det.2012.06.005 .
40. Murshed KA, Al-Bozom I, Ammar A . Sclerosing epithelioid fibrosarcoma: in-depth review of a genetically heterogeneous tumor . APMIS . 129 . 8 . 455–460 . August 2021 . 34048081 . 10.1111/apm.13157 . free .